Number of the records: 1
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial
- 1.
SYSNO ASEP 0551302 Document Type A - Abstract R&D Document Type The record was not marked in the RIV R&D Document Type Není vybrán druh dokumentu Title Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial Author(s) Rob, L. (CZ)
Mallmann, P. (DE)
Knapp, P. (PL)
Melichar, B. (CZ)
Klat, J. (CZ)
Minář, L. (CZ)
Novotný, Z. (CZ)
Bartůňková, J. (CZ)
Spíšek, R. (CZ)
Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
Bin Hassan, H. I. (CZ)
Cibula, D. (CZ)Source Title Journal of Clinical Oncology - ISSN 0732-183X
Roč. 36, 15 S (2018), s. 5509Number of pages 1 s. Language eng - English Country GB - United Kingdom UT WOS 000442916002205 DOI 10.1200/JCO.2018.36.15_suppl.5509 Workplace Institute of Computer Science Contact Tereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800 Year of Publishing 2022
Number of the records: 1